FABP4 and hematocrit: FABP4 has also been recognized as an important pathological key factor in various systemic diseases, including obesity, diabetes mellitus (DM), hypertension (HT), hyperlipidemia (HL), atherosclerosis, renal disease, metabolic dysfunction, heart events and malignancy [3,4,5,6,7,8].